¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic trypanosomiasis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • chronic meningoencephalitis
    ¸¸¼º¼ö¸·³ú¿°(¡­âÐØ¯Òàæú).
  • chronic motor or vocal tic disorder
    ¸¸¼º ¿îµ¿¼º ȤÀº À½¼ºÆ½ Àå¾Ö
  • chronic mountain sickness
    ¸¸¼º°í»êº´(¡­ÍÔߣܻ).
  • chronic myelocytic leukermia =CML
    ¸¸¼º°ñ¼ö(¼º)¹éÇ÷º´(¡­ÍéâÐàõÛÜúìÜ»).
  • chronic myelocytic leukermia =CML
    ¸¸¼º°ñ¼ö(¼º)¹éÇ÷º´(?Ë­ËàËÛËÑÌ´ËÓ).
  • chronic myelogenous leukemia
    ¸¸¼º°ñ¼ö¼º ¹éÇ÷º´.
  • chronic myelogenous leukemia
    ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´
  • chronic myelogenous leukemia
    ¸¸¼º°ñ¼ö¼º ¹éÇ÷º´.
  • chronic myelomonocytic leukemia
    ¸¸¼º °ñ¼ö¼º ´Ü±¸¹éÇ÷º´
  • chronic myeloproliferative disorder
    ¸¸¼º °ñ¼öÁõ½Ä¼º Áúȯ
  • chronic noduloulcerative angiitis
    ¸¸¼º °áÀý ±Ë¾ç¼º(Ø·àõ Ì¿ï½ Ï÷åËàõ) Ç÷°ü¿°(úìηæú)
  • chronic nonspecific dermatitis
    ¸¸¼º ºñƯÀ̼º ÇǺο°
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼â¼º ÆóÁúȯ(¡­øÍáðàõøËòðü´).
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼â¼ºÆóÁúȯ(¡­øÍáðàõøËòðü´)
  • chronic obstructive pulmonary disease
    ¸¸¼º Æó¼â¼º ÆóÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
CFS Chronic Fatigue Syndrome
CGD Chronic Granulomatous Disease; ¸¸¼º À°¾ÆÁ¾ Áúȯ
Chr Chronic; ¸¸¼º
CIDP Chronic Inflammatory Demyelinating Poly(radiculo)neuropathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CCS Chronic Compartment Syndrome
CF Chronic Fatigue
CFS Chronic Fatigue Syndrome
CGD chronic granulomatous disese
CHF Chronic Heart Failure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic subdural hemorrhage
    ¸¸¼º °æ¸·ÇÏ ÃâÇ÷
  • chronic superficial gastritis
    ¸¸¼º Ç¥À缺 À§¿°
  • chronic suppurative osteomyelitis
    ¸¸¼º È­³ó¼º °ñ¼ö¿°
    ±Þ¼º¿¡ ºñÇØ ¸ðµç Áõ»óÀÌ ¾àÇÏ´Ù. ±Þ¼ºÀ¸·Î ¾ÇÈ­°¡ ÁÖ±âÀûÀ¸·Î µÈ´Ù. Ä¡·á´Â Àß ¾ÈµÇ°í Àç¹ßÀÌ ½±´Ù.
  • chronic syndromes
    ¸¸¼º ÁõÈıº
  • chronic thyroiditis
    ¸¸¼º °©»ó¼±¿°
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • chronic ulcer
    ¸¸¼º ±Ë¾ç
  • chronic ulcerative pulpitis
    ¸¸¼º ±Ë¾ç¼º Ä¡¼ö¿°
    ³ëÃâµÈ Ä¡¼ö Ç¥¸é¿¡ ³ó¾ç Çü¼º Áï ±Ë¾çÀÌ Æ¯Â¡ÀÌ´Ù. ¸¸¼º ¿°Áõ »óÅÂ. ÀþÀº »ç¶÷ÀÇ Ä¡¼ö, ³ªÀ̰¡ ¸¹Àº »ç¶÷¿¡¼­ ¾àÇÑ °¨¿°¿¡ ÀúÇ×ÇÒ ¸¸ÇÑ °Ç°­ÇÑ Ä¡¼ö¿¡ º¼ ¼ö ÀÖ´Ù.
  • chronic urethritis
    ¸¸¼º ¿äµµ¿°
  • chronic vasometer instability
    ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤, ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • pemphigus chronic vulgaris
    ¸¸¼º ½É»ó¼º õÆ÷â
    ÀÚ°¡ ¸é¿ª¼º ¼öÆ÷¼º ÁúȯÀ¸·Î¼­ ÁÖ·Î ÇÇºÎ¿Í Á¡¸·¿¡ ¹ß»ýÇÑ´Ù. Ư¡Àû ÀÚ°¡ Ç×üÀÇ ¸ñÇ¥ ÁöÁ¡Àº »óÇÇÀÇ ¼¼Æ÷°£±³ º¹ÇÕüÀÌ´Ù. ÀÌ·¯ÇÑ Á¶Á÷°ú ÀÚ°¡ Ç×ü°¡ ¹ÝÀÀÇϸé, ¼¼Æ÷ °áÇÕÀÌ ÆÄ±«µÇ¾î »óÆÐÀÇ ºÐ¸®°¡ ¾ß±âµÈ´Ù. À¯ÀüÀû ¿äÀÎÀÌ ÀÌ Áúȯ°ú °ü·Ã ÀÖ´Ù. ½É»ó¼º õÆ÷âÀÇ Ç¥ÇÇ ¹× Á¡¸· ¼Ò°ßÀº ÀϽÃÀûÀ̸ç, ¸¼Àº ¼ö¾×À¸·Î ä¿öÁø ¼Ò¼öÆ÷ ¹× ¼öÆ÷°¡ ³ªÅ¸³µ´Ù°¡ ÅÍÁüÀ¸·Î¼­ ±Ë¾çÀÌ µÇ´Âµ¥ ºÎºÐÀûÀ¸·Î´Â À¯¾àÇÑ ¸·À¸·Î µ¤¿©Áø °ÍÀ» º¼ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ È¯ÀÚ´Â Áß³â ÀÌÈÄ¿¡ ³ªÅ¸³ªÁö¸¸ ¾î¸°À̳ª ÀþÀºÀÌ¿¡°Ôµµ ¹ß»ý ÇÒ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ ÀÚ°¡ ¸é¿ª Áúȯ°ú ¸¶Âù°¡Áö·Î Ä¡·á´Â ÄÚ¸®Æ¼ÄÚ ½ºÅ×·ÎÀ̵带 ±¹¼Ò µµÆ÷ ¹× Àü½Å Åõ¿©ÇÏ´Â µî ¸é¿ª¾ïÁ¦Á¦¿¡ ÀÇÁ¸ÇÑ´Ù.
  • severe, painful, chronic arthritis
    ½ÉÇÑ ÅëÁõ¼º ¸¸¼º °üÀý¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
chronic interstitial hepatitis An obsolete term for cirrhosis of the liver.
(05 Mar 2000)
chronic interstitial hypertrophic neuropathy dejerine-Sottas disease
chronic interstitial salpingitis Salpingitis in which fibrosis or mononuclear cell infiltration involves all layers of the fallopian or eustachian tube.
Synonym: pachysalpingitis.
(05 Mar 2000)
chronic kidney failure Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. If renal function declines to a low enough level (end-stage renal disease) kidney dialysis may be necessary. A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
chronic leukaemia A persistent cancer of the blood, usually of gradual onset and generally of slow progression. May be diagnosed by chance following a routine blood test and prior to the appearance of clinical symptoms.
Origin: Gr. Haima = blood
(13 Nov 1997)
chronic lymphadenoid thyroiditis <endocrinology> Inflammation of the thyroid gland without the formation of pus. Noninfectious nonbacterial thyroid inflammation.
(27 Sep 1997)
chronic lymphocytic leukaemia <haematology> A slowly progressing form of leukaemia, characterised by an increased number of the type of white blood cell known as lymphocytes. With about 3, 500 new cases occurring each year in the UK, it is the most common form of leukaemia and occurs predominantly in late middle age onwards. It has variable symptoms and course, but may be diagnosed by chance before the patient develops any clinical symptoms of disease.
Acronym: CLL
Origin: Gr. Haima = blood
(12 Jan 1998)
chronic lymphocytic thyroiditis <endocrinology> Inflammation of the thyroid gland without the formation of pus. Noninfectious nonbacterial thyroid inflammation.
(27 Sep 1997)
chronic malaria Malaria that develops after frequently repeated attacks of one of the acute forms, usually falciparum malaria; it is characterised by profound anaemia, enlargement of the spleen, emaciation, mental depression, sallow complexion, oedema of ankles, feeble digestion, and muscular weakness.
Synonym: limnaemia, malarial cachexia.
(05 Mar 2000)
chronic mountain sickness Loss of high altitude tolerance after prolonged exposure (e.g., by residence), characterised by extreme polycythemia, exaggerated hypoxaemia, and reduced mental and physical capacity; relieved by descent.
Synonym: altitude erythraemia, chronic soroche, Monge's disease.
(05 Mar 2000)
chronic myeloid leukaemia <haematology> A leukaemia which is initially slowly-progressing. There are approximately 650 new cases each year in the UK. It is characterised by the presence of large numbers of abnormal mature granulocytes, circulating in the blood.
Synonym: chronic granulocytic leukaemia.
Acronym: CML
Origin: Gr. Haima = blood
(12 Jan 1998)
chronic myelomonocytic leukaemia <haematology> A form of myelodysplasia characterised by an increase in the number of circulating white blood cells of the monocyte type.
Acronym: CMML
Origin: Gr. Haima = blood
(12 Jan 1998)
chronic nephritis Glomerulonephritis that presents with persisting proteinuria, chronic renal failure, and hypertension, of insidious onset or as a late sequel of acute glomerulonephritis; the kidneys are symmetrically contracted and granular, with scarring and loss of glomeruli and the presence of tubular atrophy and interstitial fibrosis.
Synonym: chronic nephritis.
(05 Mar 2000)
chronic nonleukaemic myelosis A condition in which there is abnormal proliferation of leukopoietic tissue that results in immature white blood cells in the circulating blood, but the total count is within the normal range.
(05 Mar 2000)
chronic obstructive pulmonary disease <disease> A progressive disease process that most commonly results from smoking. Chronic obstructive pulmonary disease is characterised by difficulty breathing, wheezing and a chronic cough.
Treatment includes absolute avoidance from smoking, bronchodilators and oxygen for those with advanced disease. Complications include bronchitis, pneumonia and lung cancer.
See: emphysema.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á